Michael Grever, M.D.

Arthur G. James Cancer Hospital ...Columbus, Ohio - 43210-1240 |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS1
- SINCE2008

Multi-center Trial of Revlimid and Rituximab for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
February 2008 - July 2011
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Lenalidomide And Rituximab



